iZumi Bio

About:

IZumi Bio, a biotechnology company, employs cellular reprograming for the development of stem cell-based therapeutics.

Top Investors: Kleiner Perkins, Highland Capital Partners

Description:

IZumi Bio is biotechnology company focused on the application of novel technologies in cellular reprograming , including induced pluripotent stem cells and directed differantiation with the mission of creating new therapeutics.

Total Funding Amount:

$20M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

South San Francisco, California, United States

Founded Date:

2007-01-01

Contact Email:

info(AT)izumibio.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2009-04-14

IPO Status:

Private

Industries: